Skip to content

Investigating the effect of increasing awareness based on Acceptance and Commitment Therapy on the quality of life of women with HPV

Investigating the effect of increasing awareness based on Acceptance and Commitment Therapy on the quality of life of women with HPV referring to the Kerman women’s oncology subspecialties, 2023

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170611034452N16
Enrollment
60
Registered
2023-11-18
Start date
2023-11-14
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human papilloma virus (HPV) infection. Cervical high risk human papillomavirus (HPV) DNA test positive

Interventions

Intervention 1: Intervention group: They receive 6 group and face-to-face counseling sessions, one 90-minute session per week. Intervention 2: Control group: There is no intervention for the control g

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Positive HPV test confirmed by gynecological oncology specialist Less than 6 months have passed since the positive test result Willingness to participate in the study and complete the informed consent form Not having any neurological or mental illness Not suffering from the type Another sexually transmitted disease Being sexually active

Exclusion criteria

Exclusion criteria: Getting HPV-related cancer while studying Getting pregnant while studying If you miss more than one session and don't do your homework

Design outcomes

Primary

MeasureTime frame
Quality of Life. Timepoint: The first session of the intervention and 2 weeks after the completion of the intervention sessions. Method of measurement: Quality of life questionnaire (EQUALI-HPV).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefeh ahmadi

Kerman University of Medical Sciences

a.ahmadi@kmu.ac.ir+98 34 3132 5220

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026